Titan Bio-Tech
Ticker > Company >

Titan Bio-Tech share price

Titan Bio-Tech Ltd.

BSE: 524717 SECTOR: Chemicals  78.68 K   846   85

743.55
+35.40 (5.00%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 743.55

Today's Low

₹ 715

52 Week High

₹ 1017.85

52 Week Low

₹ 373.65

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 614.45 Cr.

Enterprise Value

₹ 618.78 Cr.

No. of Shares

0.83 Cr.

P/E

32.8

P/B

4.06

Face Value

₹ 10

Div. Yield

0.27 %

Book Value (TTM)

₹  183.08

CASH

₹ 2.84 Cr.

DEBT

₹ 7.17 Cr.

Promoter Holding

55.88 %

EPS (TTM)

₹  22.67

Sales Growth

13.94%

ROE

20.18 %

ROCE

26.3%

Profit Growth

12.55 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.94%
3 Year10.24%
5 Year23.02%

Profit Growth

1 Year12.55%
3 Year-6.31%
5 Year50.35%

ROE%

1 Year20.18%
3 Year23.52%
5 Year28.79%

ROCE %

1 Year26.3%
3 Year29.89%
5 Year33.99%

Debt/Equity

0.0558

Price to Cash Flow

29.06

Interest Cover Ratio

27.9479

CFO/PAT (5 Yr. Avg.)

0.876937675504616

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 55.88 0.00
Mar 2025 55.88 0.00
Dec 2024 55.88 0.00
Sep 2024 55.88 0.00
Jun 2024 55.88 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 23.5205% over the past 3 years.
  • Company has been maintaining healthy ROCE of 29.8937% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 27.9479.
  • The Company has been maintaining an effective average operating margins of 23.3087470173132% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 2.9711.
  • The company has a high promoter holding of 55.88%.

 Limitations

  • The company has shown a poor profit growth of -6.30902324240844% for the Past 3 years.
  • The company has shown a poor revenue growth of 10.2420204644142% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 43.12 39.89 38.28 35.17 46.5
Total Expenditure 34.87 32.13 33.43 30.6 37.76
Operating Profit 8.25 7.76 4.85 4.57 8.74
Other Income 0.62 0.32 1.59 1.38 0.72
Interest 0.31 0.27 0.15 0.08 0.2
Depreciation 1.05 1.1 1.18 0.84 1.15
Exceptional Items 0 0 0 0 0
Profit Before Tax 7.52 6.72 5.11 5.03 8.11
Tax 1.82 1.71 1.3 1.26 1.95
Profit After Tax 5.7 5 3.8 3.77 6.16
Adjusted EPS (Rs) 6.9 6.06 4.6 4.56 7.46

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 69.48 122.46 123.55 144 164.07
Total Expenditure 58.6 80.59 92.28 114.48 129.79
Operating Profit 10.88 41.87 31.27 29.52 34.28
Other Income 0.41 0.66 0.94 1.94 1.75
Interest 1.91 1.33 0.87 0.75 1.17
Depreciation 1.75 2.1 2.37 2.6 3.33
Exceptional Items 0.61 -0.32 0 0 0
Profit Before Tax 8.24 38.76 28.97 28.12 31.53
Tax 2.04 9.99 7.28 7.09 7.87
Net Profit 6.2 28.77 21.68 21.02 23.66
Adjusted EPS (Rs.) 7.5 34.82 26.24 25.44 28.64

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.26 8.26 8.26 8.26 8.26
Total Reserves 29.55 57.56 77.98 97.83 120.18
Borrowings 8.48 1.83 1.08 0.3 0.45
Other N/C liabilities 2.44 3.99 3.82 3.95 3.55
Current liabilities 17.93 24.3 23.99 27.54 26.91
Total Liabilities 66.66 95.94 115.13 137.88 159.36
Assets
Net Block 25.24 27.04 34.99 35.89 52.01
Capital WIP 0 0.27 3.63 13.29 2.53
Intangible WIP 0 0 0 0 0.02
Investments 1.27 1.27 4.03 11.59 23.18
Loans & Advances 0.58 7.77 1.52 1.35 1.29
Other N/C Assets 0 0.18 0.16 0.26 0.36
Current Assets 39.57 59.4 70.79 75.49 79.96
Total Assets 66.66 95.94 115.13 137.88 159.36
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 8.24 38.76 28.97 28.12 31.53
Adjustment 3.86 3.62 3.52 3.52 4.76
Changes in Assets & Liabilities -3.64 -14.64 -3.33 -2.96 -7.28
Tax Paid -1.54 -10.16 -7.12 -7.5 -7.87
Operating Cash Flow 6.92 17.59 22.04 21.18 21.15
Investing Cash Flow -0.94 -4.17 -16.44 -20.73 -20.3
Financing Cash Flow -5.87 -9.81 -4.1 -2.4 -2.87
Net Cash Flow 0.11 3.61 1.51 -1.95 -2.02

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 55.88 55.88 55.88 55.88 55.88
connoisseur management se... - - - - 6.78
madhu gupta 0.80 0.80 0.80 0.80 0.80
manju singla 0.86 0.86 0.86 0.86 0.86
naresh kumar singla 0.42 0.42 0.42 0.42 0.42
naresh kumar singla huf 0.12 0.12 0.12 0.12 0.12
raja singla 0.74 0.74 0.74 0.74 0.74
ravinder gupta 0.10 0.10 0.10 0.10 0.10
shivom singla 0.43 0.43 0.43 0.43 0.43
supriya singla 0.66 0.66 0.66 0.66 0.66
suresh chand singla 1.28 1.28 1.28 1.28 1.28
tanita leasing & finance ... 9.49 9.49 9.49 9.49 9.49
titan securities ltd 33.59 33.59 33.59 33.59 33.59
udit singla 0.61 0.61 0.61 0.61 0.61
connoisseur management se... 6.78 6.78 6.78 6.78 -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 44.12 44.12 44.12 44.12 44.12
investor education and pr... 8.81 8.80 9.29 9.28 9.26
manish goel - 1.57 1.65 - 1.74
ankit goyal - - - 1.57 -
mukesh panjwani 1.15 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.Report us

Titan Bio-Tech Stock Price Analysis and Quick Research Report. Is Titan Bio-Tech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Titan Bio-Tech. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Titan Bio-Tech has a PE ratio of 32.8002999691208 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Titan Bio-Tech has ROA of 15.9219% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Titan Bio-Tech has a Current ratio of 2.9711.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Titan Bio-Tech has a ROE of 20.1789%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Titan Bio-Tech has a Debt to Equity ratio of 0.0558 which means that the company has low proportion of debt in its capital.

  • Sales growth: Titan Bio-Tech has reported revenue growth of 13.9395% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Titan Bio-Tech for the current financial year is 20.8941069200675%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Titan Bio-Tech is Rs 2 and the yield is 0.269%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Titan Bio-Tech is Rs 22.669. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Titan Bio-Tech in Ticker for free. Also, one can get the intrinsic value of Titan Bio-Tech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Titan Bio-Tech FAQs

Q1. What is Titan Bio-Tech share price today?
Ans: The current share price of Titan Bio-Tech is Rs 743.55.

Q2. What is the market capitalisation of Titan Bio-Tech?
Ans: Titan Bio-Tech has a market capitalisation of Rs 614.4474135 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Titan Bio-Tech?
Ans: The PE ratio of Titan Bio-Tech is 32.8002999691208 and the P/B ratio of Titan Bio-Tech is 4.06126166475952, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Titan Bio-Tech share?
Ans: The 52-week high share price of Titan Bio-Tech is Rs 1017.85, and the 52-week low share price of Titan Bio-Tech is Rs 373.65.

Q5. Does Titan Bio-Tech pay dividends?
Ans: Currently, Titan Bio-Tech pays dividends. Dividend yield of Titan Bio-Tech is around 0.269%.

Q6. What are the face value and book value of Titan Bio-Tech shares?
Ans: The face value of Titan Bio-Tech shares is Rs 10, while the book value per share of Titan Bio-Tech is around Rs 183.0835. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Titan Bio-Tech?
Ans: Titan Bio-Tech has a total debt of Rs 7.1709 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Titan Bio-Tech?
Ans: The ROE of Titan Bio-Tech is 20.1789% and ROCE of Titan Bio-Tech is 26.2956%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Titan Bio-Tech a good buy for the long term?
Ans: The Titan Bio-Tech long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Titan Bio-Tech undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Titan Bio-Tech appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Titan Bio-Tech’s financials?
Ans: You can review Titan Bio-Tech’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Titan Bio-Tech
X